Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Unknown 1Suspended 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Other 1Classical hematology 1

Conditions

Neoplasms 14Pain 13Pain, Postoperative 12Cancer Pain 10Agnosia 7Chronic Pain 6Colorectal Neoplasms 4Colonic Neoplasms 4Breast Neoplasms 4Neoplasm Metastasis 3Mucositis 3Lung Neoplasms 3Head and Neck Neoplasms 3Supratentorial Neoplasms 2Pancreatic Neoplasms 2Pain, Intractable 2Neoplastic Cells, Circulating 2Multiple Myeloma 2Lymphoma 2Leukemia, Myeloid, Acute 2Leukemia, Biphenotypic, Acute 2Leukemia 2Inflammation 2Ileus 2Hematologic Neoplasms 2Wounds and Injuries 1Waldenstrom Macroglobulinemia 1Vesico-Ureteral Reflux 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1

Interventions

Ketamine 3Morphine 2Methadone 2Dexmedetomidine 2ziconotide 1substance P-saporin 1Sodium Chloride 1Ropivacaine 1Registries 1Passive Cutaneous Anaphylaxis 1Midazolam 1Lidocaine 1Infusion Pumps, Implantable 1Hydromorphone 1Calcium Dobesilate 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Pain, Intractable × Morphine × Clear all
NCT06940570 2025-10-23

MATCH

University of Texas Southwestern Medical Center

Phase 3 Suspended
60 enrolled
Classical hematologyOtherOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Aplastic, Leukemia, Neoplasms, Pain, Intractable, Mucositis

NCT02687347 2016-09-20

UDOME

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase 3 Unknown
204 enrolled

Pain, Intractable

Data powered by HemOnc (CC BY 4.0) Colophon âš¡